NCT01205321 - PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2011

Conditions

Diagnostic Imaging

Interventions

DRUG

Bombesin (68Ga) labeled (BAY86-7548)

Cancer patients, single intravenous bolus injection of 140 MBq BAY86-7548 on day one of the treatment period, PET/CT

DRUG

Bombesin (68Ga) labeled (BAY86-7548)

Healthy volunteers, single intravenous bolus injection of 140 MBq BAY86-7548 on day one of the treatment period, whole body PET/CT for determination of effective dose, kinetics of BAY86-7548 in blood

Trial Locations (3)

8091

Zurich

89081

Ulm

FIN-20521

Turku